Details for: RNU6 6P

Gene ID: 26826

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RNU6 6P

Ensembl ID: ENSG00000272055

Description: RNA, U6 small nuclear 6, pseudogene

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • cardiac endothelial cell CL0010008
    CSI 2.67
    rCSI 10.77%
    PRS 99.11
  • BEST4+ enteroycte CL4030026
    CSI 2.44
    rCSI 3.03%
    PRS 98.65

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RNU6 6P](/details-gene/26826) is a pseudogene derived from the U6 small nuclear RNA (snRNA), a critical component of the spliceosome. Located on chromosome 10p13, it is generally presumed to be non-functional. However, expression data suggests it may be transcribed in a highly cell-type-specific manner. **Overall**, it shows notable expression significance in distinct cell populations, including [cardiac endothelial cells](/details-cell/CL0010008) and [BEST4+ enteroyctes](/details-cell/CL4030026), suggesting a potential, though currently uncharacterized, context-dependent regulatory role. ## Cellular Roles and Expression Landscape The expression profile of [RNU6 6P](/details-gene/26826) is not broadly characterized, but available data points to a highly restricted expression pattern. **Overall**, the gene's significance is most pronounced in two functionally and developmentally distinct cell types: * **Vascular System:** [cardiac endothelial cell](/details-cell/CL0010008) (CSI: 2.67) * **Gastrointestinal System:** [BEST4+ enteroycte](/details-cell/CL4030026) (CSI: 2.44) The significant expression in these disparate cell types suggests that if [RNU6 6P](/details-gene/26826) has a biological function, it is not related to a common developmental lineage. Instead, its role may be tied to specific cellular states or processes shared between these specialized cells, such as ion transport, fluid balance, or response to specific microenvironmental signals. The lack of broader expression data precludes a more detailed analysis of its cellular specificity. ## Pathways and Molecular Function As a pseudogene, [RNU6 6P](/details-gene/26826) is not annotated in canonical pathway databases, and it is not expected to be translated into a functional protein. Its parent gene, U6 snRNA, is essential for pre-mRNA splicing by forming part of the catalytic core of the spliceosome. However, it is highly unlikely that [RNU6 6P](/details-gene/26826) participates directly in this process. If the transcript of [RNU6 6P](/details-gene/26826) is functional, it would most likely act as a non-coding RNA. Potential functions could include acting as a microRNA sponge (competing endogenous RNA, or ceRNA) to regulate the expression of other genes, or serving as a scaffold for protein complexes, thereby influencing chromatin structure or transcription. ## Research Directions The specific expression of the pseudogene [RNU6 6P](/details-gene/26826) in cardiac endothelial and BEST4+ intestinal cells raises intriguing questions about its potential regulatory function. Further investigation is required to move beyond correlational observations. **Proposed Hypotheses:** 1. The [RNU6 6P](/details-gene/26826) transcript acts as a competing endogenous RNA (ceRNA) in [cardiac endothelial cells](/details-cell/CL0010008), sequestering specific microRNAs that are critical for regulating vascular homeostasis or angiogenesis. 2. Transcription of [RNU6 6P](/details-gene/26826) is not itself functional but serves as a sensitive biomarker for a particular state of cellular stress or metabolic activity common to both cardiac endothelium and BEST4+ enterocytes. **Experimental Approach:** To test the ceRNA hypothesis (Hypothesis 1), a multi-step approach could be employed. First, confirm the expression and quantify the absolute abundance of the [RNU6 6P](/details-gene/26826) transcript in primary human [cardiac endothelial cells](/details-cell/CL0010008) using digital droplet PCR. Second, use *in silico* prediction tools to identify potential microRNA binding sites on the [RNU6 6P](/details-gene/26826) sequence. Third, overexpress or knockdown [RNU6 6P](/details-gene/26826) in a cardiac endothelial cell line using lentiviral vectors. The functional consequences could be assessed by measuring changes in the expression of predicted microRNA target genes via RNA-seq and qPCR, and by performing functional assays such as tube formation or cell migration assays. **Therapeutic Potential:** The therapeutic potential of [RNU6 6P](/details-gene/26826) is highly speculative and entirely dependent on confirmation of a functional role. If it is found to be a key ceRNA that promotes pathological processes in cardiac endothelial cells (e.g., atherosclerosis or heart failure), it could represent a novel target for inhibition. Therapies based on antisense oligonucleotides (ASOs) could be designed to specifically degrade the [RNU6 6P](/details-gene/26826) transcript. However, extensive foundational research is required to first validate its function before any therapeutic development can be considered.